<DOC>
	<DOCNO>NCT02142283</DOCNO>
	<brief_summary>The purpose study evaluate hypothesis Trevo thrombectomy plus medical management lead superior clinical outcome 90 day compare medical management alone appropriately select subject experience acute ischemic stroke treatment initiate within 6-24 hour last see well .</brief_summary>
	<brief_title>Clinical Mismatch Triage Wake Up Late Presenting Strokes Undergoing Neurointervention With Trevo</brief_title>
	<detailed_description>The study prospective , randomize , multi-center , Phase II/III ( feasibility/pivotal ) , adaptive , controlled trial , design demonstrate mechanical thrombectomy use Trevo Retriever medical management superior medical management alone improve clinical outcome 90 day appropriately select wake late presenting acute ischemic stroke subject . The intent study support use Trevo Retriever beyond currently label 8 hour indicated time limit wake , unclear onset , late presenting ischemic stroke subject , currently option besides medical management symptom . Patients wake-up stroke , stroke unclear onset time , witness late presenting stroke may potentially benefit intra-arterial reperfusion therapy . However , important indicator whether subject benefit late time window confirmation large vessel occlusion ( LVO ) , assessment core infarct volume relative volume salvageable penumbra . Therefore , standardize image selection subject require inclusion study . This trial design subject safety mind , seamless Phase II ( feasibility ) / Phase III ( pivotal ) adaptive design , order address concern around potential unknown harm enrol subject . This study help answer question whether carefully select subject use Clinical Imaging Mismatch allow acute ischemic stroke patient present beyond 6 hour Time Last Seen Well ( TLSW ) consider intra-arterial intervention . If Trevo thrombectomy plus medical management lead well clinical outcome medical management alone , patient future could receive endovascular treatment ( either addition lieu IV tPA ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>General 1 . Clinical sign symptom consistent diagnosis acute ischemic stroke , subject belong one follow subgroup : 1 . Subject fail IV tPA therapy ( define confirm persistent occlusion 60 min administration ) 2 . Subject contraindicate IV tPA administration 2 . Age ≥18 3 . Baseline NIHSS ≥10 ( assess within one hour measure core infarct volume ) 4 . Subject randomize 6 24 hour time last know well 5 . No significant prestroke disability ( prestroke mRS must 0 1 ) 6 . Anticipated life expectancy least 6 month 7 . Subject willing/able return protocol require follow visit 8 . Subject subject 's Legally Authorized Representative ( LAR ) sign study Informed Consent form* If approve local ethic committee country regulation , investigator allow enroll patient utilize emergency inform consent procedure neither patient representative person trust available sign inform consent form . However , soon possible , patient inform his/her consent request possible continuation research . ( Not applicable U.S . Sites . ) Imaging 1 . &lt; 1/3 MCA territory involve , evidence CT MRI 2 . Occlusion intracranial ICA and/or MCAM1 evidence MRA CTA 3 . Clinical Imaging Mismatch ( CIM ) define one follow MRDWI CTPrCBF map : 1 . 0 &lt; 21 cc core infarct NIHSS ≥ 10 ( age ≥ 80 year old ) 2 . 0 &lt; 31 cc core infarct NIHSS ≥ 10 ( age &lt; 80 year old ) 3 . 31 cc &lt; 51 cc core infarct NIHSS ≥ 20 ( age &lt; 80 year old ) General 1 . History severe head injury within past 90 day residual neurological deficit , determine medical history 2 . Rapid improvement neurological status NIHSS &lt; 10 evidence vessel recanalization prior randomization 3 . Preexisting neurological psychiatric disease would confound neurological functional evaluation , e.g . dementia prescribe anticholinesterase inhibitor ( e.g . Aricept ) 4 . Seizures stroke onset make diagnosis stroke doubtful precludes obtain accurate baseline NIHSS assessment 5 . Baseline blood glucose &lt; 50mg/dL ( 2.78 mmol ) &gt; 400mg/dL ( 22.20 mmol ) 6 . Baseline hemoglobin count &lt; 7 mmol/L 7 . Baseline platelet count &lt; 50,000/uL 8 . Abnormal baseline electrolyte parameter define sodium concentration &lt; 130 mmol/L , potassium concentration &lt; 3 mEq/L &gt; 6 mEq/L 9 . Renal failure define serum creatinine &gt; 3.0 mg/dL ( 264 µmol/L ) NOTE : subject renal dialysis may treat regardless serum creatinine level 10 . Known hemorrhagic diathesis , coagulation factor deficiency , anticoagulant therapy INR &gt; 3.0 PTT &gt; 3 time normal . Patients factor Xa inhibitor 2448 hour ago must normal PTT . 11 . Any active recent hemorrhage within past 30 day 12 . History severe allergy ( rash ) contrast medium 13 . Severe , sustain hypertension ( Systolic Blood Pressure &gt; 185 mmHg Diastolic Blood Pressure &gt; 110 mmHg ) NOTE : If blood pressure successfully reduce maintain acceptable level use medication subject enrol 14 . Female pregnant lactating time admission 15 . Current participation another investigational drug device study 16 . Presumed septic embolus , suspicion bacterial endocarditis 17 . Treatment clear thrombectomy device intraarterial ( neurovascular ) therapy prior randomization Imaging 1 . Evidence intracranial hemorrhage CT/MRI 2 . CTA MRA evidence flow limit carotid dissection , highgrade stenosis , complete cervical carotid occlusion require stenting time index procedure ( i.e. , mechanical thrombectomy ) . 3 . Excessive tortuosity cervical vessel CTA/MRA would likely preclude device delivery/deployment 4 . Suspected cerebral vasculitis base medical history CTA/MRA 5 . Suspected aortic dissection base medical history CTA/MRA 6 . Intracranial stent implant vascular territory would preclude safe deployment/removal Trevo device 7 . Occlusions multiple vascular territory ( e.g. , bilateral anterior circulation , anterior circulation/vertebrobasilar system ) confirm CTA/MRA , clinical evidence bilateral stroke stroke multiple territory 8 . Significant mass effect midline shift confirm CT/MRI 9 . Evidence intracranial tumor ( except small meningioma ) confirm CT/MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Mechanical thrombectomy</keyword>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>Wake stroke</keyword>
	<keyword>Late presenting stroke</keyword>
</DOC>